Business Context and Reporting Period
Company: Inmune Bio, Inc. (Nevada corporation, NASDAQ: INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2021
Event: Announcement of a conference call to discuss financial results for the first quarter ended March 31, 2021, and provide a corporate update.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a notification of an upcoming conference call where such data will be discussed.
Material Changes
No material financial changes or comparative period data are disclosed in this filing. The document references a press release (Exhibit 99.1) containing the announcement but does not include the financial details within the text provided.
Guidance, Outlook, and Risks
Outlook/Management Commentary: Management scheduled a conference call for Wednesday, May 5, 2021, at 4:30 PM Eastern Time to discuss Q1 2021 results and corporate updates.
Risks/Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific Q1 2021 financial figures.
- Confirm attendance or access to the conference call scheduled for May 5, 2021, at 4:30 PM ET.
- Review the company's status as an emerging growth company for potential differences in financial reporting standards.